T&L Co., Ltd. (KOSDAQ:340570)

South Korea flag South Korea · Delayed Price · Currency is KRW
47,400
+300 (0.64%)
At close: Oct 30, 2025
0.64%
Market Cap382.61B
Revenue (ttm)185.32B
Net Income (ttm)45.67B
Shares Out8.07M
EPS (ttm)5,658.37
PE Ratio8.38
Forward PE7.45
Dividend750.00 (1.59%)
Ex-Dividend DateDec 27, 2024
Volume61,874
Average Volume36,246
Open47,900
Previous Close47,100
Day's Range47,000 - 48,950
52-Week Range45,800 - 85,600
Beta0.09
RSI39.69
Earnings DateNov 14, 2025

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1998
Employees 242
Stock Exchange KOSDAQ
Ticker Symbol 340570
Full Company Profile

Financial Performance

In 2024, T&L Co., Ltd.'s revenue was 174.89 billion, an increase of 51.47% compared to the previous year's 115.46 billion. Earnings were 46.41 billion, an increase of 69.13%.

Financial Statements

News

There is no news available yet.